Hey - CNN Settles Lawsuit with Covington Catholic Student

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone Steel Reserve #65227
159
Hey - CNN Settles Lawsuit with Covington Catholic Student Nick Sandmann
< >

Covington-Instagram-420x315.jpg

CNN has agreed to settle a $275 million lawsuit brought by Covington Catholic student Nick Sandmann over the network’s coverage of a confrontation involving himself and his classmates and a Native American man during a school trip to Washington, D.C., last year, FOX 19 reported Tuesday.

The terms of the settlement were not publicized during the hearing at the federal courthouse in Covington, Kentucky. Sandmann sought $800 million in damages from CNN, the Washington Post, and NBC Universal. Lawsuit again the latter news outlets are still pending.

“This case will be tried not one minute earlier or later than when it is ready,” Lin Wood, an attorney for the student, said of the lawsuits.

Sandmann and his classmates were accused of mocking Native American activist Nathan Phillips while wearing a red “Make America Great Again” baseball hat during last January’s March for Life event.

Both Sandmann and Phillips said they were trying to defuse tensions that were rising among three groups on a day Washington hosted both the anti-abortion event, attended by the Covington students, and the Indigenous Peoples March. But video of Sandmann and Phillips standing very close to each other, with Sandmann staring and at times smiling at Phillips as he sang and played a drum, gave some who watched it a different impression.

Interpretations changed over the days following the incident as witnesses released more cellphone video footage. Phillips had approached Sandmann, but well before that, both his group and Sandmann’s were confronted by a third group that appeared to be affiliated with the Black Hebrew Israelite movement.

Videos show members of the religious group yelling disparaging and profane insults at the students, some of whom shouted back. Video also shows the Native Americans being insulted by the small religious group. Sandmann’s legal team has released its own video, “Nick Sandmann: The Truth in 15 Minutes.” It shows scenes from the confrontation, clips from news coverage and interviews, and examples of harsh Tweets and comments aimed at Sandmann and his high school.

In an interview with NBC’s Today, Sandmann said that while he had a right to stand by Phillips, he wishes the incident unfolded differently. “As far as standing there, I had every right to do so,” the student told interviewer Savannah Guthrie. “My position is that I was not disrespectful to Mr. Phillips. I respect him. I’d like to talk to him. I mean, in hindsight, I wish we could have walked away and avoided the whole thing. But I can’t say that I’m sorry for listening to him and standing there.”

“In hindsight, I wish we had just found another spot to wait for our buses, but at the time being positive seemed better than letting them slander us with all of these things,” he added. “So, I wish we could have walked away.”

Sandmann then explained he did not walk away from the activist as he was concerned it would have been viewed as disrespectful. “Well, now I wish I would have walked away. I didn’t want to be disrespectful to Mr. Phillips and walk away if he was trying to talk to me, but certainly I was surrounded by a lot of people I didn’t know that had their phones out, had cameras and I didn’t want to bump into anyone or seem like I was trying to do something,” he said.

President Donald Trump expressed support for Sandmann after he sued the Washington Post, tweeting: “Go get them, Nick. Fake News!”

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Narcolepsy Market: Innovations Ahead

Updated Category News Views 166

The Evolving Landscape of the Narcolepsy Market The narcolepsy market is undergoing significant changes as it shifts from merely managing symptoms to developing targeted therapies that tackle the root causes of the disorder. Traditionally, treatments focused on alleviating symptoms, but advancements now emphasize addressing the underlying neurochemical issues, primarily...

Continue Reading
UBS Analysts Share Insights on China Stocks Strategies

Updated Category News Views 242

UBS Analysts Offer Insights on China's Equity Market In a recent discussion, UBS strategists have expressed a level of caution regarding China's equity market as they look into the evolving landscape of 2025. It's noted that local A-share investors appear hesitant to seize buying opportunities, influenced by a myriad of factors that create uncertainty in the market....

Continue Reading
Palisade Bio's Special Meeting Cancellation: What You Need to Know

Updated Category News Views 133

Palisade Bio Cancels Special Meeting of Stockholders Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company making strides in developing innovative treatments for autoimmune, inflammatory, and fibrotic diseases. Recently, the company announced an important decision regarding its special meeting of stockholders. The special meeting, originally...

Continue Reading
Vivendi Reports Impressive 4.5% Revenue Growth in 2024

Updated Category News Views 123

Remarkable Revenue Growth for Vivendi Vivendi has announced an impressive increase in its revenues for the first nine months of 2024, emphasizing strong growth across its core business sectors. The company reported a revenue increase of 4.5% at constant currency and perimeter, compared to the same period in the previous year. This growth showcases the resilience and...

Continue Reading
Revolution in Home Renovation Arrives with Spray-Net Franchise

Updated Category News Views 226

Fresh Approach to Home Makeovers Home remodeling isn’t just about slapping on a new coat of paint anymore. In February 2026, Spray-Net is gearing up to launch in Allen, Texas, shaking things up in the renovation game. This venture represents a leap forward—not only for franchise growth but for homeowners who are sick and tired of traditional, drawn-out renovations....

Continue Reading